Error loading player: No playable sources found

3549382

Production of high specific activity rhenium-186 via the 186W(d,2n)186Re nuclear reaction using pressed tungsten-186 metal targets and evaluation of separation methods

Date
April 7, 2021

Rhenium-186 (t1/2 = 3.72 d) is a highly desirable radionuclide that emits therapeutic β- particles with a β-max energy of 1.07 MeV, allowing for a targeted tissue range of up to 3.6 mm. In addition, its 137 keV (8.6%) gamma emission makes it suitable for theranostic applications. Currently, low specific activity 186Re is produced in a reactor via the 185Re(n,g)186Re nuclear reaction, but demand for high specific activity 186Re for targeted radiotherapy applications can potentially be met using charged-particle activation of 186W targets via the 186W(d,2n)186Re nuclear reaction.

A graphite-encased 186W metal target (99.9% enriched) was prepared by uniaxially pressing 186W metal powder between two layers of graphite flakes with 13.8 MPa of hydraulic pressure. The target was bombarded with 22 MeV deuterons for a total of 27 μAh, with an estimated incident deuteron energy of 19.5 MeV on the 186W metal layer. Following a cool-down period to allow co-produced W-187 to decay, the target was dissolved using 30% H2O2 and then divided into two aliquots. Separation of the 186Re product in these aliquots was evaluated using an Analig Tc-02 resin column procedure and a methyl ethyl ketone (MEK) solvent extraction procedure. The isolated 186Re product was evaluated by radiolabeling a 222-MAMA-N-propionate ligand. Further studies were performed to optimize separation yield conditions by varying resin type, loading solution, and target mass.

An EOB 186Re yield of 0.611 GBq (16.5 mCi) was obtained after a 27 μAh deuteron bombardment. We report a method for the production and separation of high specific activity 186Re from the deuteron bombardment of graphite-encased 186W metal targets. Both separation methods resulted in high recovery yields of 186Re, which was then successfully used to radiolabel a 222-MAMA-N-propionate ligand.
Figure 1: HPLC gamma chromatogram of radiolabeling reaction mixture showing radiolabeled <sup>186</sup>Re- MAMA at 9 minutes and <sup>186</sup>ReO<span style=4- at 2.7 minutes (20-80 % H2O/MeCN in 20 minutes."/>

Figure 1: HPLC gamma chromatogram of radiolabeling reaction mixture showing radiolabeled 186Re- MAMA at 9 minutes and 186ReO4- at 2.7 minutes (20-80 % H2O/MeCN in 20 minutes.


Related Products

Thumbnail for Separation of radiolanthanides using advanced liquid-liquid extraction techniques
Separation of radiolanthanides using advanced liquid-liquid extraction techniques
One area of radiopharmaceutical research is the production of high specific activity theranostic radionuclides due to their potential to advance personalized medicine…
Thumbnail for Production of high specific activity rhenium radioisotopes for radiotherapeutic applications
Production of high specific activity rhenium radioisotopes for radiotherapeutic applications
Therapeutic radioisotope demand has increased due to growing successes with therapeutic radiopharmaceuticals in the clinic…
Thumbnail for Evaluation of alpha irradiation of [153Eu]Eu2O3 and [155Gd]Gd2O3 targets for producing high specific activity 155Tb
Evaluation of alpha irradiation of [153Eu]Eu2O3 and [155Gd]Gd2O3 targets for producing high specific activity 155Tb
Several terbium (Tb) radioisotopes hold high promise for the development of theranostic agents due to their diagnostic and therapeutic emissions. Those radioisotopes include 149Tb, 152Tb, 155Tb, and 161Tb…
Thumbnail for Investigation of a new resin for development of 72Se/72As radioisotope generator
Investigation of a new resin for development of 72Se/72As radioisotope generator
Arsenic-77 (t1/2 = 38.8 h; Eβ-max = 0.683 MeV) and 72As (t1/2 = 26.0 h; Eβ+max = 3.334 MeV) are radioisotopes that can be used as a theranostic matched pair. Arsenic-72 is the decay product of 72Se (t1/2 = 8.4 d; ε = 100%) and forms the basis of a potential 72Se/72As generator…